Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer

Figure 6

Higher expression of MRPL13 was correlated to higher TMB levels in BRCA. (a–e) Our results show expression of MRPL13 was correlated to TMB levels in BRCA, luminal A BRCA, luminal B BRCA, HER2-enriched BRCA, and TNBC patients.

(a)

(b)

(c)

(d)

(e)